MA49396B1 - Traitement de la migraine avec acétyl-leucine - Google Patents
Traitement de la migraine avec acétyl-leucineInfo
- Publication number
- MA49396B1 MA49396B1 MA49396A MA49396A MA49396B1 MA 49396 B1 MA49396 B1 MA 49396B1 MA 49396 A MA49396 A MA 49396A MA 49396 A MA49396 A MA 49396A MA 49396 B1 MA49396 B1 MA 49396B1
- Authority
- MA
- Morocco
- Prior art keywords
- leucine
- migraine
- acetyl
- treatment
- subject
- Prior art date
Links
- 208000019695 Migraine disease Diseases 0.000 title abstract 3
- WXNXCEHXYPACJF-ZETCQYMHSA-N N-acetyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(C)=O WXNXCEHXYPACJF-ZETCQYMHSA-N 0.000 title abstract 3
- 229960000669 acetylleucine Drugs 0.000 title abstract 3
- 206010027599 migraine Diseases 0.000 title abstract 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1709459.0A GB201709459D0 (en) | 2017-06-14 | 2017-06-14 | Treatment for migraine |
| PCT/IB2018/054676 WO2018229738A1 (en) | 2017-06-14 | 2018-06-25 | Treatment for migraine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA49396A MA49396A (fr) | 2020-04-22 |
| MA49396B1 true MA49396B1 (fr) | 2021-03-31 |
Family
ID=59358204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA49396A MA49396B1 (fr) | 2017-06-14 | 2018-06-25 | Traitement de la migraine avec acétyl-leucine |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US11471434B2 (enExample) |
| EP (1) | EP3638370B1 (enExample) |
| JP (1) | JP7130739B2 (enExample) |
| KR (1) | KR102594130B1 (enExample) |
| CN (1) | CN111093772B (enExample) |
| AU (1) | AU2018284330B2 (enExample) |
| CY (1) | CY1123860T1 (enExample) |
| DK (1) | DK3638370T3 (enExample) |
| ES (1) | ES2847169T3 (enExample) |
| GB (1) | GB201709459D0 (enExample) |
| HR (1) | HRP20210108T1 (enExample) |
| HU (1) | HUE053089T2 (enExample) |
| IL (1) | IL271211B2 (enExample) |
| LT (1) | LT3638370T (enExample) |
| MA (1) | MA49396B1 (enExample) |
| MD (1) | MD3638370T2 (enExample) |
| MX (1) | MX387909B (enExample) |
| PL (1) | PL3638370T3 (enExample) |
| PT (1) | PT3638370T (enExample) |
| RS (1) | RS61481B1 (enExample) |
| SG (1) | SG11201912146RA (enExample) |
| SI (1) | SI3638370T1 (enExample) |
| SM (1) | SMT202100037T1 (enExample) |
| WO (1) | WO2018229738A1 (enExample) |
| ZA (1) | ZA201908087B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3091353A1 (en) * | 2018-02-15 | 2019-08-22 | Intrabio Ltd | Therapeutic agents for treating restless legs syndrome |
| BR112021010923A2 (pt) | 2018-12-06 | 2021-08-24 | Intrabio Ltd | Análogos deuterados de acetileucina |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8701662L (sv) * | 1987-04-22 | 1988-10-23 | Gelder Nico M Van | Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna |
| US20040127501A1 (en) * | 2002-09-24 | 2004-07-01 | Zhengming Chen | Therapeutic agents useful for treating pain |
| US20060063827A1 (en) | 2004-09-23 | 2006-03-23 | Yu Ruey J | Systemic administration of therapeutic amino acids and N-acetylamino acids |
| MY142655A (en) * | 2003-06-12 | 2010-12-15 | Euro Celtique Sa | Therapeutic agents useful for treating pain |
| SI1641775T1 (sl) * | 2003-07-03 | 2009-08-31 | Euro Celtique Sa | 2-piridin alkinski derivati, uporabni za zdravljenje bolečine |
| EP2080757A1 (en) * | 2003-07-24 | 2009-07-22 | Euro-Celtique S.A. | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| DE602004017481D1 (de) * | 2003-09-22 | 2008-12-11 | Euro Celtique Sa | Zur behandlung von schmerzen geeignete therapeutische mittel |
| PT2017276E (pt) * | 2003-09-22 | 2011-04-05 | Euro Celtique Sa | Compostos de fenilcarboxamida úteis para o tratamento da dor |
| CN1902178A (zh) * | 2003-12-30 | 2007-01-24 | 欧洲凯尔特公司 | 用于治疗疼痛的哌嗪 |
| FR2905600B1 (fr) * | 2006-09-13 | 2010-01-15 | Pf Medicament | Traitement des vertiges par l'acetyl-l-leucine. |
| TN2010000251A1 (fr) | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| JP5876423B2 (ja) * | 2010-06-22 | 2016-03-02 | 塩野義製薬株式会社 | Ｔｒｐｖ１阻害活性を有する化合物とその使用 |
| EP2588130B1 (en) | 2010-06-25 | 2016-08-17 | Shire Human Genetic Therapies, Inc. | Cns delivery of therapeutic agents |
| EP3536368B1 (en) * | 2010-11-09 | 2025-09-17 | MannKind Corporation | Dry powder inhaler comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
| AU2012293417A1 (en) * | 2011-08-10 | 2013-05-02 | Purdue Pharma L.P. | TRPV1 antagonists including dihydroxy substituent and uses thereof |
| WO2017182802A1 (en) | 2016-04-19 | 2017-10-26 | Intrabio Ltd | Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function |
| KR102467953B1 (ko) | 2016-08-11 | 2022-11-16 | 인트라바이오 리미티드 | 리소좀 축적 질환과 관련된 약제 조성물 및 용도 |
| MA43828B1 (fr) | 2016-08-11 | 2019-09-30 | Intrabio Ltd | Agents thérapeutiques pour maladies neurodégénératives |
| WO2018178670A1 (en) | 2017-03-28 | 2018-10-04 | Intrabio Ltd | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject |
| MA50399A (fr) | 2017-10-18 | 2020-08-26 | Intrabio Ltd | Agents thérapeutiques pour mobilité et fonction cognitive améliorées et pour le traitement de maladies neurodégénératives et de troubles de stockage lysosomal |
| SG11202003390UA (en) | 2017-10-18 | 2020-05-28 | Intrabio Ltd | Therapeutic agents for neurodegenerative diseases |
| CA3091353A1 (en) | 2018-02-15 | 2019-08-22 | Intrabio Ltd | Therapeutic agents for treating restless legs syndrome |
| BR112021010923A2 (pt) | 2018-12-06 | 2021-08-24 | Intrabio Ltd | Análogos deuterados de acetileucina |
| KR20250171484A (ko) | 2019-03-02 | 2025-12-08 | 인트라바이오 리미티드 | 질환을 치료하기 위한 류신, 아세틸 류신, 및 관련된 유사체 |
| US20220362189A1 (en) | 2019-06-28 | 2022-11-17 | Intrabio Ltd. | Combination therapy with acetyl-leucine and miglustat |
| WO2021144720A1 (en) | 2020-01-13 | 2021-07-22 | Intrabio Ltd | Treatment of late-onset neurodegenerative diseases in heterozygous npc1 gene mutation carriers |
-
2017
- 2017-06-14 GB GBGB1709459.0A patent/GB201709459D0/en not_active Ceased
-
2018
- 2018-06-25 AU AU2018284330A patent/AU2018284330B2/en active Active
- 2018-06-25 LT LTEP18749124.6T patent/LT3638370T/lt unknown
- 2018-06-25 SI SI201830195T patent/SI3638370T1/sl unknown
- 2018-06-25 EP EP18749124.6A patent/EP3638370B1/en active Active
- 2018-06-25 PT PT187491246T patent/PT3638370T/pt unknown
- 2018-06-25 PL PL18749124T patent/PL3638370T3/pl unknown
- 2018-06-25 SG SG11201912146RA patent/SG11201912146RA/en unknown
- 2018-06-25 MX MX2019014784A patent/MX387909B/es unknown
- 2018-06-25 RS RS20210046A patent/RS61481B1/sr unknown
- 2018-06-25 HU HUE18749124A patent/HUE053089T2/hu unknown
- 2018-06-25 WO PCT/IB2018/054676 patent/WO2018229738A1/en not_active Ceased
- 2018-06-25 IL IL271211A patent/IL271211B2/en unknown
- 2018-06-25 HR HRP20210108TT patent/HRP20210108T1/hr unknown
- 2018-06-25 MD MDE20200433T patent/MD3638370T2/ro unknown
- 2018-06-25 ES ES18749124T patent/ES2847169T3/es active Active
- 2018-06-25 KR KR1020197038730A patent/KR102594130B1/ko active Active
- 2018-06-25 US US16/622,785 patent/US11471434B2/en active Active
- 2018-06-25 CN CN201880039532.2A patent/CN111093772B/zh active Active
- 2018-06-25 MA MA49396A patent/MA49396B1/fr unknown
- 2018-06-25 DK DK18749124.6T patent/DK3638370T3/da active
- 2018-06-25 JP JP2020519196A patent/JP7130739B2/ja active Active
- 2018-06-25 SM SM20210037T patent/SMT202100037T1/it unknown
-
2019
- 2019-12-05 ZA ZA2019/08087A patent/ZA201908087B/en unknown
-
2021
- 2021-01-18 CY CY20211100033T patent/CY1123860T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52219B1 (fr) | Traitement de l'hidradénite suppurée à l'aide d'inhibiteurs de jak | |
| MA43468B1 (fr) | Méthodes de traitement de la dépression à l'aide d'antagonistes de récepteurs de l'orexine-2 | |
| MA39726A (fr) | Compositions pharmaceutiques de composés thérapeutiquement actifs | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| MA39725B1 (fr) | Compositions pharmaceutiques de composés thérapeutiquement actifs | |
| MA43828A (fr) | Agents thérapeutiques pour maladies neurodégénératives | |
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| MA35156B1 (fr) | 4-amino-5-fluoro-3-[6-(4-méthylpipérazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinoléin-2-one destinée à être utilisée dans le traitement du carcinome adénoïde kystique | |
| EA201490277A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| MA44612B1 (fr) | Méthodes de traitement de cancers pédiatriques | |
| MA40768B1 (fr) | Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue | |
| MA35513B1 (fr) | Compositions pharmaceutiques comprenant 40 - o - ( 2 - hydroxy) éthyl - rapamycine | |
| JOP20220104A1 (ar) | نظام تجريع لعوامل مضادة لـ dll3 | |
| MA55199B1 (fr) | (n-)acétyl-l-leucine pour le traitement des lésions cérébrales traumatiques | |
| CA2986891C (en) | Compositions for use in treating parkinson's disease and related disorders | |
| HRP20211824T1 (hr) | Modulatori aktivnosti komplementa | |
| ZA201901370B (en) | Formulations for oral administration of active agents | |
| MA62992B1 (fr) | Formulations de capsules | |
| MA43876B1 (fr) | Compositions pharmaceutiques et leur utilisations contre les maladies de surcharge lysosomale | |
| MA49396A (fr) | Traitement de la migraine avec acétyl-leucine | |
| MA54511B1 (fr) | Composition ophtalmique nutraceutique pour le traitement de pathologies retiniennes a composante neovasculaire | |
| MA46778B1 (fr) | Composition intranasale comprenant de la bétahistine | |
| TN2010000108A1 (fr) | Traitement de symtomes vasomoteurs | |
| MA50383B1 (fr) | Agents thérapeutiques pour l'utilisation dans le traitement du syndrome des jambes sans repos | |
| FR3047665B1 (fr) | Celastrol et ses derives dans le traitement des tumeurs et pathologies pre-cancereuses cutanees |